SCHEMBL650989

SCHEMBL650989

CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1cc(F)cc(C(F)(F)F)c1)CC1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.39
UBE2M P61081 3/20 0.38
DCUN1D1 Q96GG9 3/20 0.38
CRHR1 P34998 5/20 0.36
CCR4 P51679 1/20 0.35
BCHE P06276 1/20 0.35
TACR1 P25103 1/20 0.34
TSHR P16473 2/20 0.33
HDAC1 Q13547 1/20 0.33
TRPV4 Q9HBA0 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SGMS1 Q86VZ5 1/20 0.33
SGMS2 Q8NHU3 1/20 0.33
ADORA1 P30542 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL650021 0.95 C5AR1 (0.41) C5AR1CRHR1CCR4BCHETACR1
SCHEMBL650474 0.94 C5AR1 (0.42) C5AR1UBE2MDCUN1D1CRHR1CCR4
SCHEMBL650435 0.90 C5AR1 (0.42) C5AR1UBE2MDCUN1D1CRHR1CCR4
SCHEMBL5134723 0.89 C5AR1 (0.42) C5AR1CRHR1CCR4BCHETSHR
SCHEMBL5137114 0.88 C5AR1 (0.43) C5AR1CRHR1BCHETSHRHDAC1
SCHEMBL647725 0.87 C5AR1 (0.41) C5AR1UBE2MDCUN1D1CRHR1TACR1
SCHEMBL5137864 0.86 C5AR1 (0.44) C5AR1BCHETSHRHDAC1KDM4E
SCHEMBL649769 0.86 C5AR1 (0.40) C5AR1UBE2MDCUN1D1CRHR1CCR4
SCHEMBL651006 0.86 C5AR1 (0.42) C5AR1UBE2MDCUN1D1CRHR1CCR4
SCHEMBL646859 0.86 C5AR1 (0.39) C5AR1UBE2MDCUN1D1CRHR1CCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed